Browsing: divi’s laboratories

Hawkish signals by the US Federal Reserve (Fed) ended the Nifty50’s eight-day gaining streak on Friday. The 50-share index…

Shares of Divi’s Laboratories rallied 4 per cent to Rs 3,407 on the BSE in Tuesday’s intra-day trade. In the…

By Shrikant Chouhan The benchmark indices bounced back sharply, the NSE Nifty 50 ended 289 points higher and the BSE…

Divi’s Laboratories’ (Divi’s) Q4FY22 performance beat our estimates across parameters. Consolidated revenues grew 40.8% y-o-y to Rs 25.2 bn, Ebitda…

Domestic stock markets were moving between gains and losses on Tuesday as volatility zoomed past 25 levels. S&P BSE Sensex…

Indian equity markets were flat on Friday. Given the global developments, market volatility is expected to remain high in the…

Jefferies India remains bullish on the Indian pharma companies, as it believes that Indian contract development and manufacturing companies are…

BSE Sensex and Nifty 50 had been trading at record higher levels on Thursday, extending the preceding day’s rally. Headline…

Merck (also recognized as MSD outdoors the US and Canada) and companion Ridgeback Biotherapeutics announced sturdy benefits from the interim…

Glenmark Life Sciences is probably to finalise the IPO share allotment on Tuesday, 3 August 2021. The Rs 1,513.6-crore public…